ask="1.48"
ask_size="200"
average_daily_volume="162283"
bid="1.18"
bid_size="200"
book_value="0.33"
change="+0.01"
change_from_200_day_moving_average="-0.49"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-2.28"
change_From_52_week_low="0.39"
change_in_percent="+0.84%"
close="1.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-19.61M"
eps_estimate_current_year="-0.72"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.62"
ex_dividend_date="N/A"
float_shares="25247000"
high="1.26"
high_52_weeks="3.48"
last_trade_date="3/1/2017"
last_trade_price="1.20"
last_trade_size="1470"
last_trade_time="4:00pm"
low="1.19"
low_52_weeks="0.81"
market_capitalization="30.51M"
moving_average_200_day="1.69"
moving_average_50_day="1.26"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.25"
open="1.26"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-28.96%"
percent_change_from_50_day_moving_average="-4.92%"
percent_change_from_52_week_high="-65.52%"
percent_change_from_52_week_low="+48.33%"
previous_close="1.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.57"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="4.86"
stock_exchange="NCM"
symbol="RPRX"
volume="79101"
weeks_range_52="0.81 - 3.48"
